Description

Tapderimotide (hTERT (691–705)) is an immunological agent for active immunization[1][2].—COVID-19-immunoregulation–C79H129N25O22—-[1]Mizukoshi E, et al. Telomerase-Targeted Cancer Immunotherapy. Int J Mol Sci. 2019;20(8):1823. Published 2019 Apr 12.|[2]Robertson JS, et al. International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety. Vaccine. 2022;40(1):21-27.–1221082-45-6–1781.02—-O=C([C@H]1N(CCC1)C([C@H](CC(O)=O)NC([C@H](CCC(N)=O)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](C(C)C)NC([C@@H](NC([C@H]([C@H](O)C)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC2=CC=CC=C2)=O)=O)=O)=O)=O)=O)=O)=O)=O)N3[C@@H](CCC3)C(N4[C@@H](CCC4)C(N[C@H](C(O)=O)CCC(O)=O)=O)=O–Inflammation/Immunology–10 mM in DMSO–Others—-Others–Peptides